Andrew Coop

5.9k citations
154 papers · 4.6k · 1 hit paper · h-index 32

Impact in

  • Toxicology top 0.2%
    • Forensic Toxicology and Drug Analysis
    • Neuropeptides and Animal Physiology
    • Neurotransmitter Receptor Influence on Behavior
    • Neuroscience and Neuropharmacology Research

Papers in

    • Pharmacological Receptor Mechanisms and Effects 52
    • Receptor Mechanisms and Signaling 38
    • Neuropeptides and Animal Physiology 49
    • Neuroscience and Neuropharmacology Research 21
    • Neurotransmitter Receptor Influence on Behavior 18

Andrew Coop

152 papers receiving 4.5k citations

Andrew Coop's Hit Papers

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial 2001 · 789 citations
7890+8+16Years since publication250500750

Peers

Andrew Coop
Comparison fields: 5 of 119
  • Toxicology 444
  • Cellular and Molecular Neuroscience 1.3k
  • Cancer Research 598
  • Oncology 915
  • Pharmacology 278
Replace Gregory R. J. Thatcher with:
Gregory R. J. Thatcher United States
M. Strolin Benedetti Italy
Brenda C. Crews United States
Stefanie D. Krämer Switzerland
Claire Lugnier France
Vincent Setola United States
María L. López-Rodrı́guez Spain
Victor J. Lotti United States
Camille G. Wermuth France
Rayudu Gopalakrishna United States
Andrew Coop relative to Gregory R. J. Thatcher United States Gregory R. J. Thatcher's profile →
Citations per field
00.5×4.9×
Gregory R. J. Thatcher · 1×
Citations per year

Countries citing papers authored by Andrew Coop

Since Specialization
Citations

This map shows the geographic impact of Andrew Coop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Coop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Coop more than expected).

Fields of papers citing papers by Andrew Coop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Coop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Coop. The network helps show where Andrew Coop may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Coop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Coop Line = papers co-authored together Andrew Coop links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial
Hit paper breakdown →
2001789
2 2001262
3 2010227
4 2010192
5
Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.
2003167
6 2003102
7
Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.
200293
8 200593
9 200787
10 200684
11 201175
12 200974
13 200269
14 200562
15 200854
16 200852
17 200452
18
Binding characteristics of the gamma-hydroxybutyric acid receptor antagonist [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain.
200152
19 200347
20 200745

About Andrew Coop

Andrew Coop is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Organic Chemistry, Toxicology and Physiology, having authored 154 papers that have together received 4.6k indexed citations. Recurring topics across this work include Pharmacological Receptor Mechanisms and Effects (52 papers), Neuropeptides and Animal Physiology (49 papers), Receptor Mechanisms and Signaling (38 papers), Neuroscience and Neuropharmacology Research (21 papers), Forensic Toxicology and Drug Analysis (18 papers), Neurotransmitter Receptor Influence on Behavior (18 papers), Pain Mechanisms and Treatments (14 papers) and Asymmetric Synthesis and Catalysis (12 papers). The work is most often cited by research in Toxicology (444 citations), Cellular and Molecular Neuroscience (1.3k citations), Cancer Research (598 citations), Oncology (915 citations) and Pharmacology (278 citations). Andrew Coop has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Alexander D. MacKerell, Matthew J. Ellis, William R. Miller, F. Jänicke, L. Mauriac, Erhard Quebe‐Fehling, Dean B. Evans, James E. Polli, Baljit Singh and Dean Y. Maeda. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact